These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7835264)

  • 1. Umbilical vein injection for retained placenta: clinical feasibility study of a new technique.
    Pipingas A; Gulmezoglu AM; Mitri FF; Hofmeyr GJ
    East Afr Med J; 1994 Jun; 71(6):396-7. PubMed ID: 7835264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a place for intra-umbilical oxytocin for the management of retained placenta?
    Sivalingam N; Surinder S
    Med J Malaysia; 2001 Dec; 56(4):451-9. PubMed ID: 12014765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta?
    Lim PS; Singh S; Lee A; Muhammad Yassin MA
    Arch Gynecol Obstet; 2011 Nov; 284(5):1073-9. PubMed ID: 21136267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraumbilical injection of three different uterotonics in the management of retained placenta.
    Harara R; Hanafy S; Zidan MS; Alberry M
    J Obstet Gynaecol Res; 2011 Sep; 37(9):1203-7. PubMed ID: 21518127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intra-umbilical oxytocin in the management of retained placenta: a randomized controlled trial.
    Samanta A; Roy SG; Mistri PK; Mitra A; Pal R; Naskar A; Bhattacharya SK; Pal PP; Pande A
    J Obstet Gynaecol Res; 2013 Jan; 39(1):75-82. PubMed ID: 22889466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraumbilical oxytocin for management of retained placenta.
    Makkonen M; Suonio S; Saarikoski S
    Int J Gynaecol Obstet; 1995 Feb; 48(2):169-72. PubMed ID: 7540566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intraumbilical vein oxytocin injection on third stage of labor.
    Nankali A; Keshavarzi F; Fakheri T; Zare S; Rezaei M; Daeichin S
    Taiwan J Obstet Gynecol; 2013 Mar; 52(1):57-60. PubMed ID: 23548219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Release Trial: a randomised controlled trial of umbilical vein oxytocin versus placebo for the treatment of retained placenta.
    Weeks A; Mirembe F; Alfirevic Z
    BJOG; 2005 Oct; 112(10):1458. PubMed ID: 16167963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta.
    Rogers MS; Yuen PM; Wong S
    Acta Obstet Gynecol Scand; 2007; 86(1):48-54. PubMed ID: 17230289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta.
    Bider D; Dulitzky M; Goldenberg M; Lipitz S; Mashiach S
    Eur J Obstet Gynecol Reprod Biol; 1996 Jan; 64(1):59-61. PubMed ID: 8801151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraumbilical veinous injection oxytocin in the active management of third stage of labour.
    Tehseen F; Anwar A; Arfat Y
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):551-4. PubMed ID: 18803892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of a retained placenta with intraumbilical oxytocin injection.
    Habek D; Hrgović Z; Ivanisević M; Delmis J
    Zentralbl Gynakol; 2001 Jul; 123(7):415-7. PubMed ID: 11534303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual nitroglycerin seems to be effective in the management of retained placenta.
    Ekerhovd E; Bullarbo M
    Acta Obstet Gynecol Scand; 2008; 87(2):222-5. PubMed ID: 18231892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Umbilical vessel oxytocin administration for retained placenta: in vitro study of various infusion techniques.
    Pipingas A; Hofmeyr GJ; Sesel KR
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):793-5. PubMed ID: 8456881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The retained placenta.
    Weeks AD
    Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1103-17. PubMed ID: 18793876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbetocin versus intra-umbilical oxytocin in the management of retained placenta: a randomized clinical study.
    Elfayomy AK
    J Obstet Gynaecol Res; 2015 Aug; 41(8):1207-13. PubMed ID: 25976063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial.
    Weeks AD; Alia G; Vernon G; Namayanja A; Gosakan R; Majeed T; Hart A; Jafri H; Nardin J; Carroli G; Fairlie F; Raashid Y; Mirembe F; Alfirevic Z
    Lancet; 2010 Jan; 375(9709):141-7. PubMed ID: 20004013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial.
    Gazvani MR; Luckas MJ; Drakeley AJ; Emery SJ; Alfirevic Z; Walkinshaw SA
    Obstet Gynecol; 1998 Feb; 91(2):203-7. PubMed ID: 9469276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical vein injection of oxytocin for retained placenta.
    Ekele B; Morhason-Bello I
    Lancet; 2010 Jan; 375(9709):98-9. PubMed ID: 20004012
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraumbilical injection of uterotonics for retained placenta.
    Habek D; Franicević D
    Int J Gynaecol Obstet; 2007 Nov; 99(2):105-9. PubMed ID: 17603061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.